Jun‐Kyu Byun

1.4k total citations · 1 hit paper
25 papers, 965 citations indexed

About

Jun‐Kyu Byun is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jun‐Kyu Byun has authored 25 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Jun‐Kyu Byun's work include Cancer, Hypoxia, and Metabolism (7 papers), Immune cells in cancer (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Jun‐Kyu Byun is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Immune cells in cancer (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Jun‐Kyu Byun collaborates with scholars based in South Korea, United States and Norway. Jun‐Kyu Byun's co-authors include Keun‐Gyu Park, Yeon‐Kyung Choi, Jonghwa Jin, In‐Kyu Lee, Jaebon Lee, Seunghyeong Lee, Jae Won Yun, Sung Jin Cho, You Mie Lee and Mi Kyung Kim and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Hepatology.

In The Last Decade

Jun‐Kyu Byun

25 papers receiving 955 citations

Hit Papers

Targeting glutamine metabolism as a therapeutic strategy ... 2023 2026 2024 2025 2023 50 100 150 200 250

Peers

Jun‐Kyu Byun
Hee Chan Yoo South Korea
Ya Chun Yu South Korea
Yulseung Sung South Korea
Ahmad A. Cluntun United States
Hayley C. Affronti United States
Sarah Yoon South Korea
Yariswamy Manjunath United States
Hee Chan Yoo South Korea
Jun‐Kyu Byun
Citations per year, relative to Jun‐Kyu Byun Jun‐Kyu Byun (= 1×) peers Hee Chan Yoo

Countries citing papers authored by Jun‐Kyu Byun

Since Specialization
Citations

This map shows the geographic impact of Jun‐Kyu Byun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Kyu Byun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Kyu Byun more than expected).

Fields of papers citing papers by Jun‐Kyu Byun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Kyu Byun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Kyu Byun. The network helps show where Jun‐Kyu Byun may publish in the future.

Co-authorship network of co-authors of Jun‐Kyu Byun

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Kyu Byun. A scholar is included among the top collaborators of Jun‐Kyu Byun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Kyu Byun. Jun‐Kyu Byun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Daehoon, Jonghwa Jin, Yu Rim Lee, et al.. (2025). SLC25A33-mediated mitochondrial DNA synthesis plays a critical role in the inflammatory response of M1 macrophages by contributing to mitochondrial ROS and VDAC oligomerization. International Journal of Biological Sciences. 21(7). 2935–2953. 1 indexed citations
2.
Byun, Jun‐Kyu & Gwon‐Soo Jung. (2024). Gemigliptin mitigates TGF-β-induced renal fibrosis through FGF21-mediated inhibition of the TGF-β/Smad3 signaling pathway. Biochemical and Biophysical Research Communications. 733. 150425–150425. 1 indexed citations
3.
Jin, Jonghwa, Jaebon Lee, Jae Won Yun, et al.. (2024). Targeting YAP Activity and Glutamine Metabolism Cooperatively Suppresses Tumor Progression by Preventing Extracellular Matrix Accumulation. Cancer Research. 84(20). 3388–3401. 7 indexed citations
4.
Kim, Dongho, Jonghwa Jin, Daehoon Kim, et al.. (2024). Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1α to induce the polarization of tumor-associated macrophages. Experimental & Molecular Medicine. 56(5). 1123–1136. 8 indexed citations
5.
Kim, Dongho, et al.. (2024). Acesulfame potassium upregulates PD-L1 in HCC cells by attenuating autophagic degradation. Biochemical and Biophysical Research Communications. 711. 149921–149921. 2 indexed citations
6.
Byun, Jun‐Kyu, Sun Hee Lee, Eui Jung Moon, et al.. (2023). Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity. British Journal of Cancer. 128(8). 1491–1502. 9 indexed citations
7.
Jin, Jonghwa, Jun‐Kyu Byun, Yeon‐Kyung Choi, & Keun‐Gyu Park. (2023). Targeting glutamine metabolism as a therapeutic strategy for cancer. Experimental & Molecular Medicine. 55(4). 706–715. 285 indexed citations breakdown →
8.
Kim, Iljin, Jieun Seo, Yo‐Han Kim, et al.. (2023). Ulmus davidiana 60% edible ethanolic extract for prevention of pericyte apoptosis in diabetic retinopathy. Frontiers in Endocrinology. 14. 1138676–1138676. 8 indexed citations
9.
Kim, Ye Jin, Jonghwa Jin, Dongho Kim, et al.. (2023). SGLT2 inhibitors prevent LPS-induced M1 macrophage polarization and alleviate inflammatory bowel disease by downregulating NHE1 expression. Inflammation Research. 72(10-11). 1981–1997. 12 indexed citations
10.
Byun, Jun‐Kyu. (2023). Tumor lactic acid: a potential target for cancer therapy. Archives of Pharmacal Research. 46(2). 90–110. 32 indexed citations
11.
Byun, Jun‐Kyu, Sang Bong Lee, Jae‐Sung Lim, et al.. (2023). N-methyl-d-aspartate receptors induce M1 polarization of macrophages: Feasibility of targeted imaging in inflammatory response in vivo. Cell & Bioscience. 13(1). 69–69. 2 indexed citations
12.
Kim, Dongho, Mi Jin Kim, Nayoung Kim, et al.. (2022). DN200434, an orally available inverse agonist of estrogen-related receptor γ, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma. BMB Reports. 55(11). 547–552. 14 indexed citations
13.
Byun, Jun‐Kyu, Seunghyeong Lee, Gilwon Kang, et al.. (2022). Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 98–98. 79 indexed citations
14.
Byun, Jun‐Kyu, et al.. (2022). Plant-exclusive domain of trans-editing enzyme ProXp-ala confers dimerization and enhanced tRNA binding. Journal of Biological Chemistry. 298(9). 102255–102255. 2 indexed citations
15.
Lee, Seunghyeong, Jun‐Kyu Byun, Nayoung Kim, et al.. (2022). Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity. BMB Reports. 55(9). 459–464. 15 indexed citations
16.
Byun, Jun‐Kyu, et al.. (2021). FoxO1 as a Regulator of Aquaporin 5 Expression in the Salivary Gland. Journal of Dental Research. 100(11). 1281–1288. 8 indexed citations
17.
Byun, Jun‐Kyu, Seunghyeong Lee, Jae Won Yun, et al.. (2020). Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity. Molecular Cell. 80(4). 592–606.e8. 159 indexed citations
18.
Byun, Jun‐Kyu, Yeon‐Kyung Choi, Ji Hyun Kim, et al.. (2017). A Positive Feedback Loop between Sestrin2 and mTORC2 Is Required for the Survival of Glutamine-Depleted Lung Cancer Cells. Cell Reports. 20(3). 586–599. 70 indexed citations
19.
Kim, Ji Hyun, Kwi-Hyun Bae, Jun‐Kyu Byun, et al.. (2017). Lactate dehydrogenase-A is indispensable for vascular smooth muscle cell proliferation and migration. Biochemical and Biophysical Research Communications. 492(1). 41–47. 61 indexed citations
20.
Jung, Gwon‐Soo, Jae‐Han Jeon, Yeon‐Kyung Choi, et al.. (2016). Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. Scientific Reports. 6(1). 30846–30846. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026